Morningstar Investor users sign in here.

Company Profile

  • Business description

    Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

  • Contact

    One Amgen Center Drive
    Thousand Oaks CA 91320-1799
    USA

    T: +1 805 447-1000

    E: investor.relations@amgen.com

    https://www.amgen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    26,700

Stocks News & Analysis

stocks

How to assess a company’s debt load

BHP is used as an example to show how to assess the impact of too much debt on financial risk and flexibility.
stocks

Top ASX banking opportunities

Bank shares rally as bad debt concerns ease but look overvalued.
video

The impact on investors from Facebook's about face on news

Morningstar's Director of Equity Research Brian Han talks about why Facebook decided not to renew media deals and the impact for the companies and investors.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,050.20 23.90 -0.30%
CAC 40 8,010.83 12.91 -0.16%
DAX 40 17,930.32 24.16 -0.13%
Dow JONES (US) 37,983.24 475.84 -1.24%
FTSE 100 7,995.58 71.78 0.91%
HKSE 16,721.69 373.34 -2.18%
NASDAQ 16,175.09 267.10 -1.62%
Nikkei 225 39,523.55 80.92 0.21%
NZX 50 Index 11,931.32 2.99 -0.03%
S&P 500 5,123.41 75.65 -1.46%
S&P/ASX 200 7,788.10 25.50 -0.33%
SSE Composite Index 3,019.47 14.77 -0.49%

Market Movers

Name
Last price
Change
% Change
The Star Entertainment Group Ltd SGR 0.51 0.04 -7.34%
Peninsula Energy Ltd PEN 0.11 0.01 -4.55%
Red 5 Ltd RED 0.43 0.03 6.17%
Sayona Mining Ltd SYA 0.04 0.00 0.00%
Judo Capital Holdings Ltd JDO 1.38 0.00 0.00%
Genex Power Ltd GNX 0.27 0.02 6.00%
Imugene Ltd IMU 0.09 0.00 -3.16%
Pantoro Ltd PNR 0.08 0.00 3.70%
Telstra Group Ltd TLS 3.76 0.04 -1.05%
Pilbara Minerals Ltd PLS 4.05 0.03 0.75%